A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

August 31, 2019

Study Completion Date

December 31, 2019

Conditions
CapsaicinUltaviolet B Light BurnNeuropathic PainLidocaine
Interventions
DRUG

Capsaicin Topical

Capsaicin patches (dosage form: patch 8% Qutenza) will be applied on 4x4 cm squared areas on the volar forearm. The patches will be left in place for 24h and 3 hours after which they will be removed.

RADIATION

Ultraviolet-B (UVB) irradiation

Two circular areas (Ø 2 cm) on the forearm are irradiated with 2 x MED (Minimal Erythema Dose) dose of UVB using a calibrated UVB machine (290-320nm wavelength), Saal Mann Multi Tester (Mann Saal, LT SBC 400 Herford, Germany).

OTHER

Histamine 1%

To deliver histamine, standard allergy skin prick test (SPT) lancets are applied. The lancets have a 1 mm shouldered tip adapt to introduce a small amount of test substance extremely locally and approximately at the dermo-epidermal junction.

DRUG

Lidocaine

Cutaneous anaesthesia will be topically induced by using EMLA cream 5%, a local anaesthetic cream consisting of equal parts of lidocaine and prilocaine (1g contains 25 mg of lidocaine and 25 mg of prilocaine)

Trial Locations (1)

9000

Silvia Lo Vecchio, Aalborg

All Listed Sponsors
lead

Aalborg University

OTHER

NCT03587220 - A Mechanistic Evaluation of the Nociceptive Desensitizing Properties of Topical Capsaicin | Biotech Hunter | Biotech Hunter